Sanguina is a wellness tool company founded in 2014 focused on the development and distribution of simple-to-use and standalone point-of-care diagnostics.
We are dedicated to developing simple, rapid testing to populations who need it most.
Safe. Simple. Quick. Accurate.
Color-based hemoglobin determination.
FDA Cleared September 2017.
Anemia is Global.
Characterized by low hemoglobin, anemia affects 2 billion annually, including 83 million in the US. Sanguina is focused on delivering affordable hemoglobin testing to populations who need it most.
Sanguina is attending the Southeastern Pediatric Research Conference: Precision Medicine at the Georgia Aquarium on June 8! This event is made possible through many of our academic and clinical partners: Georgia Tech, Emory University, Children's Healthcare of Atlanta and more. See you there!
Sanguina welcomes our new CFO, René González, and new Chief Technology Officer, Dr. Robert Mannino to the team!
AnemoCheck was cleared by the US Food & Drug Administration for clinical use. 510(k) number: K163215